FOR TYPE 2 DIABETES
Victoza® helped
me take my
blood sugar down…
Model is used for illustrative purposes only.
and changed how I manage
my type 2 diabetes.
Victoza® helps lower blood sugar when it
is high by targeting important cells in your
pancreas—called beta cells.
While not a weight-loss product, Victoza®
may help you lose some weight.
And Victoza® is used once a day anytime, with
or without food, along with eating right and
staying active.
If you’re ready for a change, talk to
your doctor about Victoza® today.
Indications and Usage:
Victoza® is an injectable prescription
medicine that may improve blood sugar
(glucose) in adults with type 2 diabetes
when used along with diet and exercise.
Victoza® is not recommended as the first
medication to treat diabetes. Victoza® is
not insulin and has not been studied in
combination with insulin. Victoza® is
not for people with type 1 diabetes or
people with diabetic ketoacidosis. It is not
known if Victoza® is safe and effective in
children. Victoza® is not recommended for
use in children.
Important Safety Information:
In animal studies, Victoza® caused thyroid
tumors—including thyroid cancer—in
some rats and mice. It is not known
whether Victoza® causes thyroid tumors
or a type of thyroid cancer called medullary
thyroid cancer (MTC) in people which
may be fatal if not detected and treated
early. Do not use Victoza® if you or any of
your family members have a history of
MTC or if you have Multiple Endocrine
Neoplasia syndrome type 2 (MEN 2). While
taking Victoza®, tell your doctor if you
get a lump or swelling in your neck,
hoarseness, trouble swallowing, or
shortness of breath. These may be
symptoms of thyroid cancer.
Inflammation of the pancreas (pancreatitis)
may be severe and lead to death. Before
taking Victoza®, tell your doctor if you have
had pancreatitis, gallstones, a history of
alcoholism, or high blood triglyceride levels
since these medical conditions make you
more likely to get pancreatitis.
Stop taking Victoza® and call your doctor
right away if you have pain in your stomach
area that is severe and will not go away,
occurs with or without vomiting, or is felt
going from your stomach area through to
your back. These may be symptoms of
pancreatitis.
Before using Victoza®, tell your doctor
about all the medicines you take, especially
sulfonylurea medicines or insulin, as taking
them with Victoza® may affect how each
medicine works.
Also tell your doctor if you are allergic to
any of the ingredients in Victoza®; have
severe stomach problems such as slowed
emptying of your stomach (gastroparesis)
or problems with digesting food; have or
have had kidney or liver problems; have
any other medical conditions; are pregnant
or plan to become pregnant. Tell your
doctor if you are breastfeeding or plan to
breastfeed. It is unknown if Victoza® will
harm your unborn baby or if Victoza®
passes into your breast milk.
Your risk for getting hypoglycemia, or low
blood sugar, is higher if you take Victoza®
with another medicine that can cause low
blood sugar, such as a sulfonylurea. The
dose of your sulfonylurea medicine may
need to be lowered while taking Victoza®.
Victoza® may cause nausea, vomiting, or
diarrhea leading to dehydration, which
may cause kidney failure. This can happen
in people who have never had kidney
problems before. Drinking plenty of fluids
may reduce your chance of dehydration.
The most common side effects with
Victoza® include headache, nausea, and
diarrhea. Nausea is most common when
first starting Victoza®, but decreases over
time in most people. Immune system-
related reactions, including hives, were
more common in people treated with
Victoza® compared to people treated with
other diabetes drugs in medical studies.
Please see Brief Summary of Important
Patient Information on next page.
If you need assistance with prescription drug costs, help
may be available. Visit pparx.org or call 1-888-4PPA-NOW.
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit fda.gov/medwatch or
call 1-800-FDA-1088.
Victoza® is a registered trademark of Novo Nordisk A/S.
© 2011 Novo Nordisk 0611-00003235-1 August 2011
